These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 4214132)
1. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide]. Rizzi G; Isaia GC Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132 [No Abstract] [Full Text] [Related]
2. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide. Artini D; Abbiati R; Orsini G; Parenti MA; Bloch K; Daturi S; Mandelli V Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091 [No Abstract] [Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic. Schmidt HA; Schoog M; Schweer KH; Winkler E Diabetologia; 1973 Sep; ():320-30. PubMed ID: 4772978 [No Abstract] [Full Text] [Related]
4. Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects. Marco J; Valverde I Diabetologia; 1973 Sep; ():317-9. PubMed ID: 4204092 [No Abstract] [Full Text] [Related]
6. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics]. Haupt E; Beyer J; Schöffling K Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557 [No Abstract] [Full Text] [Related]
7. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide. Iacono G; Ghionni A; Colucci M; Verde G; Caputo G Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166 [No Abstract] [Full Text] [Related]
8. [Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents]. Nagashima K; Inagaki N Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):737-41. PubMed ID: 19472523 [No Abstract] [Full Text] [Related]
9. A controlled study of the hypoglycemic and insulinopoietic effect of glipizide and glibenclamide in non-diabetic human subjects. Ceretti AP; Losi S; Orsini G; Emanueli A Arzneimittelforschung; 1975 Apr; 25(4):675-6. PubMed ID: 808231 [TBL] [Abstract][Full Text] [Related]
10. Effect of glipizide on a double-meal test in diabetic patients. Vailati G; Pagani G; Montini M; Caputo G; Sacchetti G Arzneimittelforschung; 1972 Nov; 22(11):1888-9. PubMed ID: 4679061 [No Abstract] [Full Text] [Related]
11. [Mechanism of action of gliquidone (author's transl)]. Zilker T; Ermler R; Henderkott U; Bottermann P Dtsch Med Wochenschr; 1975 Aug; 100(35):1733-4, 1739-41. PubMed ID: 808405 [TBL] [Abstract][Full Text] [Related]
12. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea]. Beyer J; Cordes U; Sell G; Schöffling K Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965 [No Abstract] [Full Text] [Related]
13. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas]. Beyer J; Haupt E; Cordes U; Sell G; Schöffling K Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544 [No Abstract] [Full Text] [Related]
14. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication. Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219 [TBL] [Abstract][Full Text] [Related]
15. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea. Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060 [No Abstract] [Full Text] [Related]
16. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024). Lentini S; Bossini A; Pirola LC Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124 [No Abstract] [Full Text] [Related]
17. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide. D'Onofrio F; Pempinello R; Romis L Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059 [No Abstract] [Full Text] [Related]
18. Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide. Fuccella LM; Tamassia V; Valzelli G J Clin Pharmacol New Drugs; 1973; 13(2):68-75. PubMed ID: 4631138 [No Abstract] [Full Text] [Related]
19. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide). Loubatiéres A; Mariani MM; Ribes G; Alric R Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675 [No Abstract] [Full Text] [Related]
20. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice. Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]